October 2008
Heart;Oct2008, Vol. 94 Issue 10, p1359
Academic Journal
The article offers information on several researches conducted related to cardiology. Topics include the aim of the ARISE trial (Aggressive Reduction of Inflammation Stops Events) which is to assess the effects of succinobucol (AGI-1067) on patients with acute coronary syndromes. Also included are the study on the high-density lipoprotein cholesterol and cardiovascular risk and the three antifibrinolytic agents including aprotinin, tranexamic acid, and aminocaproic acid.


Related Articles

  • Cholesteryl Ester Transfer Protein: A Potential Target for the Treatment of Coronary Artery Disease. Patel, Harsha; Jigna Shah; Patel, Sunita; Anand, I. S. // Indian Journal of Pharmaceutical Sciences;2007, Vol. 69 Issue 6, p735 

    High-density lipoprotein cholesterol levels have a strong inverse association with a risk of cardiovascular disease. Even patients on statin therapy whose low-density lipoprotein cholesterol levels are well controlled may be at high risk for developing cardiovascular disease if their...

  • Comparison of cardiovascular risk factors and biochemical profile in patients with cardiac syndrome X and obstructive coronary artery disease: A propensity score-matched study. Vasheghani-Farahani, Ali; Nouri, Nasrin; Seifirad, Soroush; Fathollahi, Mahmood Sheikh; Hakki, Elham; Alidoosti, Mohammad; Davoodi, Gholamreza; Masoudkabir, Farzad; Poorhosseini, Hamidreza // ARYA Atherosclerosis;Sep2013, Vol. 9 Issue 5, p269 

    BACKGROUND: This study was designed to compare the frequency of conventional cardiovascular disease risk factors and clinical biochemistry profile in patients with cardiac syndrome X (CSX) and obstructive coronary artery disease (CAD). METHODS: A cross-sectional study was conducted on patients...

  • Novel risk markers improve assessment of intermediate CV risk. Bryla, Suzanne; Calabro, Anthony; Costa, Samantha; DuBosar, Ryan; Foster, Melissa; Kalvaitis, Katie; Schoen, John; Talercio, Adam // Cardiology Today;Oct2012, Vol. 15 Issue 10, p58 

    The article discusses research on improvements in coronary heart disease (CHD)/cardiovascular disease (CVD) prediction accuracy and reclassification to high- and low-risk categories using six markers, referencing a study by J. Yeboah, published in a 2012 issue of the "Journal of the American...

  • Anacetrapib presents with good side-effect profile.  // Reactions Weekly;12/4/2010, Issue 1330, p2 

    The article discusses a research study on the effect of anacetrapib treatment on the high density lipoprotein (HDL) and low density lipoprotein (LDL) of patients with, or at high risk for, coronary heart disease, published in the November 17, 2010 issue of the "New England Journal of Medicine."

  • APOA1 gene polymorphisms in the South Asian immigrant population in the United States. Henkhaus, Rebecca S.; Dodani, Sunita; Manzardo, Ann M.; Butler, Merlin G. // Indian Journal of Human Genetics;Sep-Dec2011, Vol. 17 Issue 3, p194 

    BACKGROUND: Coronary artery disease (CAD) is a leading cause of death in the United States. South Asian immigrants (SAIs) from the Indian subcontinent living in the US are disproportionately at higher risk of CAD than other immigrant populations. Unique genetic factors may predispose SAIs to...

  • Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-Syndrome-Related Risk of Coronary Artery Disease. Martinelli, Nicola; Micaglio, Roberta; Consoli, Letizia; Guarini, Patrizia; Grison, Elisa; Pizzolo, Francesca; Friso, Simonetta; Trabetti, Elisabetta; Pignatti, Pier Franco; Corrocher, Roberto; Olivieri, Oliviero; Girelli, Domenico // Experimental Diabetes Research;2012, Special section p1 

    Low concentrations of plasma high-density lipoprotein (HDLs) are characteristic in metabolic syndrome (MS). The antioxidant ability of HDLs is, at least in part, attributable to pleiotropic serum paraoxonase (PON1). Different PON1 activities have been assessed in 293 subjects with (n = 88) or...

  • Raising high-density lipoprotein: for better or worse? Tomlinson, Brian // Heart;Sep2010, Vol. 96 Issue 17, p1339 

    The author comments on the study "Systematic Review: High-Density Lipoprotein (HDL) Cholesterol Increase and Non-Cardiovascular Mortality: A Meta-Analysis," by Elena Burillo et al, published within the issue. The current study offered reasons why a meta-regression analyses showing the absence of...

  • LDL i HDL holesterol u angiografski dokazanoj koronarnoj bolesti. Halilovic, Enes; Kabil, Emir; Ljuca, Farid; Nuhbegovic, Sabina; Berbic, Selma; Halilovic, Ejub // Medicinski Arhiv;2007 Supplement, Vol. 61 Issue 2, p7 

    The retrospective study included 250 patients, treated at Clinic for cardiovascular diseases of Tuzla Clinical center, between 30.08.2003. and 15.11.2004. In the coronary disease group there were 145 men, 55 women, with diagnosed coronary artery stenosis of 50% or more. The control group had 150...

  • Triglycerides and Cardiovascular Risk. Harchaoui, K. E. L.; Visser, M. E.; Kastelein, J. J. P.; Stroes, E. S.; Dallinga-Thie, G. M. // Current Cardiology Reviews;2009, Vol. 5 Issue 3, p216 

    In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics